INTERCEPT PHARMACEUTICALS, INC. (ICPT) has 186 open-market insider trades by 27 insiders since 2012. The most active filer is David Shapiro.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Genextra S.p.A. | 10% Owner | — | 7 | $471.2M | 2020-08-17 |
| Francesco Micheli | 10% Owner | — | 7 | $471.2M | 2020-08-17 |
| Jonathan Silverstein | Dir | — | 8 | $210.3M | 2015-11-24 |
| Lorenzo Tallarigo | Dir | — | 3 | $189.0M | 2014-07-07 |
| Paolo Fundaro | Dir10% Owner | — | 3 | $178.6M | 2023-11-08 |
| Samuel D. Isaly | Dir | — | 3 | $98.5M | 2015-07-17 |
| Orbimed Advisors LLC | Dir | — | 3 | $80.7M | 2015-03-26 |
| OrbiMed Capital GP IV LLC | Dir | — | 2 | $31.0M | 2014-08-09 |
| Mark Pruzanski | CEOPres | — | 20 | $29.2M | 2023-11-08 |
| Srinivas Akkaraju | Dir | — | 7 | $25.9M | 2023-11-08 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Srinivas Akkaraju | Director | Buy | $6.9M | 2021-03-10 |
| Sandip Kapadia | CFO & Treasurer | Sell | $107K | 2021-01-05 |
| Sandip Kapadia | CFO & Treasurer | Sell | $116K | 2020-12-15 |
| Jason Campagna | — | Sell | $113K | 2020-08-18 |
| Francesco Micheli | 10% Owner | Sell | $77.6M | 2020-08-13 |
| Francesco Micheli | 10% Owner | Sell | $100.8M |
Companies that share insiders with ICPT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2020-05-13 |
| Christian Weyer | EVP & Research & Development | Sell | $16K | 2020-04-27 |
| David A. Ford | Chief Human Resources Officer | Sell | $4K | 2020-04-09 |
| Christian Weyer | EVP & Research & Development | Sell | $10K | 2020-02-27 |
| Christian Weyer | VP | Sell | $136K | 2020-01-27 |
| Jason Campagna | — | Sell | $165K | 2020-01-07 |
| Gail Cawkwell | SVP & Med Affairs +1 | Sell | $33K | 2019-12-31 |
| Mark Pruzanski | President | Sell | $13K | 2019-12-31 |
| Christian Weyer | VP | Sell | $390K | 2019-12-27 |
| Mark Pruzanski | CEO & President | Sell | $52K | 2019-12-26 |